Linked Data API

Show Search Form

Search Results

1699224
star this property registered interest false more like this
star this property date less than 2024-03-26more like thismore than 2024-03-26
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care remove filter
star this property hansard heading Gender Dysphoria: Children and Young People more like this
star this property house id 2 remove filter
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask His Majesty's Government why the National Institute for Health and Care Excellence 2020 evidence review of gender-affirming hormones for children and adolescents with gender dysphoria was not referenced in the list of resources which informed NHS England’s decision on the prescription of gender-affirming hormones for children and adolescents. more like this
star this property tabling member printed
Baroness Hayter of Kentish Town more like this
star this property uin HL3614 remove filter
star this property answer
answer
unstar this property is ministerial correction false more like this
unstar this property date of answer less than 2024-04-09more like thismore than 2024-04-09
star this property answer text <p>NHS England has not adopted a new policy for gender-affirming hormones. NHS England made a consequential amendment to their gender-affirming hormones policy to bring it into alignment with the new puberty suppressing hormones policy. This planned update was set out in the puberty suppressing hormones policy consultation documents.</p><p>NHS England has put additional safeguards on the use of cross-sex hormones, for instance that any prescription to young people aged between 16 and 18 years old must be approved by a national multi-disciplinary team.</p><p>NHS England will continue to review the gender affirming hormone policy in line with the latest clinical advice, and will take note of recommendations set out in the Cass Review, once the final report has been delivered.</p> more like this
star this property answering member printed Lord Markham more like this
star this property question first answered
less than 2024-04-09T13:42:02.44Zmore like thismore than 2024-04-09T13:42:02.44Z
star this property answering member
4948
star this property label Biography information for Lord Markham more like this
star this property tabling member
4159
unstar this property label Biography information for Baroness Hayter of Kentish Town more like this